Detection of Red Blood Cell Membrane Proteins in Myelodysplastic Syndromes Using Eosin-5-Maleimide (EMA) Staining by Flow Cytometry.
Navavee UmanSirorat KobbuakleePatsita KansuwanPhandee WatanaboonyongcharoenChantana PolprasertPublished in: Hematology reports (2022)
the RBC membrane defect in low-risk MDS was not demonstrated as having detection ability using EMA binding test with flow cytometry.